Dr David Roblin, the former Site Head and Head of Research for
Pfizer's European Research & Development HQ, has begun his new
role as the Chief Operating Officer and Director of Scientific
Translation of the Francis Crick Institute.
David took over the role on the 1st September
2014 from the Crick's previous COO, John Cooper, who is remaining
as Projects Director until the institute is completed in late 2015.
David's main role is to make sure the Crick runs efficiently, the
science platforms work effectively and that the institute
accommodates world class science. However he will also focus on the
scientific agenda, identifying and developing translatable
science.
The translation agenda is of upmost importance to the Crick
given that one of its five strategic priorities is to 'accelerate
translation for health and wealth.' In summary this means
maximising the value that can be generated from the science through
translating the research into patient benefits and generating
economic opportunities for the UK.
In practice this will be a challenge. Historically biological
institutes have focused on the understanding of basic science, not
the application of that to generate health and wealth benefits.
David is keen to create a culture whereby researchers are always
asking 'how can my science be applied?' However he realises that
this is difficult to do and will take some time. "Translation is a
very different discipline and we need to work on mechanisms,
culture and support for our scientists to ask those questions of
applicability. I want to see skilled practitioners from venture
backgrounds, biotech or pharma, working with our
scientists."
David is working on a translation strategy which includes ideas
such as collaborating with our HEIs and working within their
academic health centres. Another idea is to have entrepreneurs in
residence, who are looking to create new companies and who can also
help our researchers think about how they might apply their
science. Collaborations with pharmaceutical companies will also be
a key part of the process.
With all of this to plan, as well as completing the setup of the
institute, there is definitely no shortage of things for David to
do in his new role, but he is looking forward to the
challenge. "I'm honoured and excited to be joining the Crick.
The opportunity to create an institute with such a a magnificent
and broad agenda was one not to miss. We will be creating something
unique and world class to take UK science to another level."